v. Vaccines for Diseases Caused by Microorganisms

delete UPSC Sample Notes [English]

v. Vaccines for Diseases Caused by Microorganisms

Details	The vaccine is a biological treatment that boosts resistance to a specific illness. A vaccine frequently uses weakened or killed versions of the disease-causing microbe or its toxins and typically includes an agent that mimics the microbe that causes the disease. The agent prompts the immune system to identify the microorganism as foreign, eliminate it, and “remember” it so that it can more quickly identify and eliminate any subsequent interactions with these microorganisms. For various diseases brought on by microorganisms, various kinds of vaccines are accessible. It’s them,
Inactivated vaccines	When inactivated vaccines are created, a chemical, typically formaldehyde, is used to fully kill the bacteria. The vaccine contains dead fragments of pathogen-causing microbes, typically bacteria. Since these vaccines contain dead antigens, their potency tends to wane over time, providing less long-lasting protection. Therefore, for the greatest protection, multiple doses of inactivated vaccines are typically required. The advantage of using inactivated vaccines is that there is no possibility of experiencing any symptoms associated with a disease; allergic reactions are possible but extremely uncommon. Examples of inactivated vaccines are hepatitis A, hepatitis B, poliovirus, hemophilic influenza type b, meningococcal, pneumococcal and the injected form of influenza.
Live-attenuated vaccines	Live-attenuated is simply a synonym for weak but still alive. These vaccines are created when the virus is so weak that it can reproduce in the body only 20 times. When a vaccine is created, the virus or bacteria are weakened in a lab to the point where they can still reproduce and are living, but they can no longer cause severe disease. The mere fact that it exists is sufficient to trigger the immune system to create antibodies to fend off the specific disease in the future. They are usually favoured by healthy adults because they elicit longer-lasting immunological responses. Examples include the viral diseases yellow fever, measles, rubella, and mumps and the bacterial disease typhoid.
Recombinant Vector vaccine	Immunity against illnesses with intricate infection processes can be developed by fusing the physiology of one microorganism with the DNA of another. There are presently four genetically modified vaccines on the market: A segment of the hepatitis B virus genome is inserted into the gene of a yeast cell to create hepatitis B vaccines. When the modified yeast cell multiplies, it releases only the purified hepatitis B surface antigen. The genes for a viral capsid protein are inserted into insect cell lines or yeast (like the hepatitis B vaccines) to create human papillomavirus vaccines. Particles that resemble viruses are created, and their production indicates a strong immunological reaction. Salmonella typhi bugs used in the live typhoid vaccine (Ty21a) have undergone genetic modification to render them non-pathogenic. Live attenuated influenza vaccine (LAIV) has been engineered to replicate effectively in the mucosa of the nasopharynx but not in the lungs.
DNA vaccination	A novel vaccine known as DNA vaccination has recently been developed from the DNA of an infectious pathogen. Since the DNA quality of the infection varies in complex diseases, no vaccine is effective against it. DNA vaccines function by inserting and expressing DNA into human or animal cells, which causes the immune system to recognise the virus or bacterial DNA. Immune system cells that are aware of the proteins expressed will launch an assault against the cells expressing the proteins and the proteins themselves.
Polysaccharide vaccines	The exterior capsule of some bacteria is made up of long chains of sugar molecules, and polysaccharide vaccines are a special kind of inactivated subunit vaccine made from these chains. There are pure polysaccharide immunisations for pneumococcal, meningococcal, and Salmonella typhi diseases.
Anti-Idiotypic Vaccine	An antibody’s antigen-binding site (paratope) is a representation of a portion of the antigen’s three-dimensional structure (epitope). The idiotype, or particular arrangement of amino acids in the antibody, can be thought of as a reflection of the antigen’s epitope. Injecting the antibody into another mammal will cause the antibody to be raised against the idiotype. This anti-idiotype antibody imitates a portion of the antigen’s three-dimensional structure. This is an immunisation that can be used. Antibodies (anti-anti-idiotype antibodies) that recognise a structure comparable to a part of the virus are created when the anti-idiotype antibody is injected into a vaccine. These antibodies may be able to neutralise the virus.